353 related articles for article (PubMed ID: 25451029)
1. The high-risk HPV16 E7 oncoprotein mediates interaction between the transcriptional coactivator CBP and the retinoblastoma protein pRb.
Jansma AL; Martinez-Yamout MA; Liao R; Sun P; Dyson HJ; Wright PE
J Mol Biol; 2014 Dec; 426(24):4030-4048. PubMed ID: 25451029
[TBL] [Abstract][Full Text] [Related]
2. Structural basis for subversion of cellular control mechanisms by the adenoviral E1A oncoprotein.
Ferreon JC; Martinez-Yamout MA; Dyson HJ; Wright PE
Proc Natl Acad Sci U S A; 2009 Aug; 106(32):13260-5. PubMed ID: 19651603
[TBL] [Abstract][Full Text] [Related]
3. Structure of the human Papillomavirus E7 oncoprotein and its mechanism for inactivation of the retinoblastoma tumor suppressor.
Liu X; Clements A; Zhao K; Marmorstein R
J Biol Chem; 2006 Jan; 281(1):578-86. PubMed ID: 16249186
[TBL] [Abstract][Full Text] [Related]
4. The canine papillomavirus and gamma HPV E7 proteins use an alternative domain to bind and destabilize the retinoblastoma protein.
Wang J; Zhou D; Prabhu A; Schlegel R; Yuan H
PLoS Pathog; 2010 Sep; 6(9):e1001089. PubMed ID: 20824099
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the High-Affinity Fuzzy Complex between the Disordered Domain of the E7 Oncoprotein from High-Risk HPV and the TAZ2 Domain of CBP.
Risør MW; Jansma AL; Medici N; Thomas B; Dyson HJ; Wright PE
Biochemistry; 2021 Dec; 60(51):3887-3898. PubMed ID: 34905914
[TBL] [Abstract][Full Text] [Related]
6. Different regions of the HPV-E7 and Ad-E1A viral oncoproteins bind competitively but through distinct mechanisms to the CH1 transactivation domain of p300.
Fera D; Marmorstein R
Biochemistry; 2012 Nov; 51(47):9524-34. PubMed ID: 23121466
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus type 45 E7 is a transforming protein inducing retinoblastoma protein degradation and anchorage-independent cell cycle progression.
Morandell D; Rostek U; Bouvard V; Campo-Fernández B; Fiedler M; Jansen-Dürr P; Zwerschke W
Virology; 2008 Sep; 379(1):20-9. PubMed ID: 18649911
[TBL] [Abstract][Full Text] [Related]
8. Two distinct motifs within the p53 transactivation domain bind to the Taz2 domain of p300 and are differentially affected by phosphorylation.
Jenkins LM; Yamaguchi H; Hayashi R; Cherry S; Tropea JE; Miller M; Wlodawer A; Appella E; Mazur SJ
Biochemistry; 2009 Feb; 48(6):1244-55. PubMed ID: 19166313
[TBL] [Abstract][Full Text] [Related]
9. Molecular determinants for the complex formation between the retinoblastoma protein and LXCXE sequences.
Singh M; Krajewski M; Mikolajka A; Holak TA
J Biol Chem; 2005 Nov; 280(45):37868-76. PubMed ID: 16118215
[TBL] [Abstract][Full Text] [Related]
10. Kinetic recognition of the retinoblastoma tumor suppressor by a specific protein target.
Chemes LB; Sánchez IE; de Prat-Gay G
J Mol Biol; 2011 Sep; 412(2):267-84. PubMed ID: 21787785
[TBL] [Abstract][Full Text] [Related]
11. Structural insights into TAZ2 domain-mediated CBP/p300 recruitment by transactivation domain 1 of the lymphopoietic transcription factor E2A.
Lochhead MR; Brown AD; Kirlin AC; Chitayat S; Munro K; Findlay JE; Baillie GS; LeBrun DP; Langelaan DN; Smith SP
J Biol Chem; 2020 Mar; 295(13):4303-4315. PubMed ID: 32098872
[TBL] [Abstract][Full Text] [Related]
12. Mapping the interactions of adenoviral E1A proteins with the p160 nuclear receptor coactivator binding domain of CBP.
Haberz P; Arai M; Martinez-Yamout MA; Dyson HJ; Wright PE
Protein Sci; 2016 Dec; 25(12):2256-2267. PubMed ID: 27699893
[TBL] [Abstract][Full Text] [Related]
13. Interaction between the HPV E7 oncoprotein and the transcriptional coactivator p300.
Bernat A; Avvakumov N; Mymryk JS; Banks L
Oncogene; 2003 Sep; 22(39):7871-81. PubMed ID: 12970734
[TBL] [Abstract][Full Text] [Related]
14. Mutagenesis of the pRB pocket reveals that cell cycle arrest functions are separable from binding to viral oncoproteins.
Dick FA; Sailhamer E; Dyson NJ
Mol Cell Biol; 2000 May; 20(10):3715-27. PubMed ID: 10779361
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus type 16 E6 and E7 oncoproteins interact with the nuclear p53-binding protein 1 in an in vitro reconstructed 3D epithelium: new insights for the virus-induced DNA damage response.
Squarzanti DF; Sorrentino R; Landini MM; Chiesa A; Pinato S; Rocchio F; Mattii M; Penengo L; Azzimonti B
Virol J; 2018 Nov; 15(1):176. PubMed ID: 30445982
[TBL] [Abstract][Full Text] [Related]
16. Conserved region 3 of human papillomavirus 16 E7 contributes to deregulation of the retinoblastoma tumor suppressor.
Todorovic B; Hung K; Massimi P; Avvakumov N; Dick FA; Shaw GS; Banks L; Mymryk JS
J Virol; 2012 Dec; 86(24):13313-23. PubMed ID: 23015707
[TBL] [Abstract][Full Text] [Related]
17. Protein domains governing interactions between E2F, the retinoblastoma gene product, and human papillomavirus type 16 E7 protein.
Huang PS; Patrick DR; Edwards G; Goodhart PJ; Huber HE; Miles L; Garsky VM; Oliff A; Heimbrook DC
Mol Cell Biol; 1993 Feb; 13(2):953-60. PubMed ID: 7678696
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the binding of the human papillomavirus type 16 and cottontail rabbit papillomavirus E7 proteins to the retinoblastoma gene product.
Haskell KM; Vuocolo GA; Defeo-Jones D; Jones RE; Ivey-Hoyle M
J Gen Virol; 1993 Jan; 74 ( Pt 1)():115-9. PubMed ID: 8380832
[TBL] [Abstract][Full Text] [Related]
19. E7 oncoprotein of human papillomavirus: Structural dynamics and inhibitor screening study.
Aarthy M; Kumar D; Giri R; Singh SK
Gene; 2018 Jun; 658():159-177. PubMed ID: 29535023
[TBL] [Abstract][Full Text] [Related]
20. Oligomerization properties of the viral oncoproteins adenovirus E1A and human papillomavirus E7 and their complexes with the retinoblastoma protein.
Clements A; Johnston K; Mazzarelli JM; Ricciardi RP; Marmorstein R
Biochemistry; 2000 Dec; 39(51):16033-45. PubMed ID: 11123931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
